1-20 of 20
Term: DRUG RESISTANCE
Volume: 20
Issue: suppl_6
Sort by
Journal Article
DRES-05. MOLECULAR EVOLUTION OF DIFFUSE GLIOMAS AND THE GLIOMA LONGITUDINAL ANALYSIS CONSORTIUM
Roel Verhaak and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi76, https://doi.org/10.1093/neuonc/noy148.312
Published: 05 November 2018
Journal Article
DRES-06. PREVENTING THE EMERGENCE OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA BY PARP-1 INHIBITION
Alice Yuan and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi76–vi77, https://doi.org/10.1093/neuonc/noy148.313
Published: 05 November 2018
Journal Article
DRES-09. IN VIVO FUNCTIONAL GENOMICS IDENTIFIES DRIVERS OF CHEMORESISTANCE IN MEDULLOBLASTOMA
Ana Guerreiro Stücklin and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi77, https://doi.org/10.1093/neuonc/noy148.316
Published: 05 November 2018
Journal Article
DRES-16. HYPOXIC MICROENVIRONMENT DETECTED BY FRP-170 PET MAY INDUCE THE EXPRESSION OF DRUG RESISTANCE GENES IN THE PATIENT WITH GLIOBLASTOMA
Tatsuya Abe and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi78–vi79, https://doi.org/10.1093/neuonc/noy148.323
Published: 05 November 2018
Journal Article
DRES-17. ACTIVATION OF FGF SIGNALING PATHWAY CONFERS RESISTANCE TO EGFR INHIBITION IN GBM
Gao Guo and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi79, https://doi.org/10.1093/neuonc/noy148.324
Published: 05 November 2018
Journal Article
DRES-19. THE MECHANISMS OF RESISTANCE TO TEMOZOLOMIDE IN GLIOMA CELLS
Shigeo Ohba and Yuichi Hirose
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi79, https://doi.org/10.1093/neuonc/noy148.326
Published: 05 November 2018
Journal Article
DRES-08. DYNAMIC KINOME PROFILING OF GENETICALLY-DEFINED, EGFRvIII-DRIVEN MURINE ASTROCYTE MODELS OF GLIOBLASTOMA REVEALS TARGETS FOR DUAL KINASE INHIBITOR THERAPY
Erin Smithberger and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi77, https://doi.org/10.1093/neuonc/noy148.315
Published: 05 November 2018
Journal Article
DRES-13. VEGF BLOCKADE ENHANCES T REGULATORY CELL FUNCTION BY DYSREGULATING GLUTAMATE TRANSPORT IN GBM
Yu Long and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi78, https://doi.org/10.1093/neuonc/noy148.320
Published: 05 November 2018
Journal Article
DRES-14. PROTEIN AGGREGATE FORMATION PREDICTS CLINICAL RESPONSES TO EGFR TKIs
Pim French and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi78, https://doi.org/10.1093/neuonc/noy148.321
Published: 05 November 2018
Journal Article
DRES-15. GSK3 BETA AND hnRNPA1 (RNA BINDING PROTEIN) COOPERATES WITH cMyc TRANSCRIPTIONAL REGULATOR, ANTAGONIZES GSK3 ALPHA UNDER THERAPEUTIC STRESS
Ajay Yadav and Vidhi Vashistha
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi78, https://doi.org/10.1093/neuonc/noy148.322
Published: 05 November 2018
Journal Article
DRES-20. THE TNF RECEPTOR FAMILY MEMBER Fn14 IS HIGHLY EXPRESSED IN RECURRENT GLIOBLASTOMA (GBM) AND IN GBM PATIENT-DERIVED XENOGRAFTS WITH ACQUIRED TEMOZOLOMIDE RESISTANCE
David Hersh and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi79–vi80, https://doi.org/10.1093/neuonc/noy148.327
Published: 05 November 2018
Journal Article
DRES-03. EGFR-TARGETED THERAPY-INDUCED RESISTANCE MECHANISM IN MALIGNANT GLIOMAS
Inah Hwang and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi75–vi76, https://doi.org/10.1093/neuonc/noy148.310
Published: 05 November 2018
Journal Article
DRES-01. ZEB1-MEDIATED INVASIVE MESENCHYMAL TRANSITION AT THE SINGLE CELL LEVEL PROMOTES ANTI-ANGIOGENIC THERAPY RESISTANCE IN GLIOBLASTOMA
Ankush Chandra and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi75, https://doi.org/10.1093/neuonc/noy148.308
Published: 05 November 2018
Journal Article
DRES-02. CILIARY PROTEIN ARL13B PROMOTES CHEMORESISTANCE BY MODULATE GLIOBLASTOMA PURINE BIOSYNTHESIS
Jack Shireman and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi75, https://doi.org/10.1093/neuonc/noy148.309
Published: 05 November 2018
Journal Article
DRES-04. CHARACTERIZATION OF A MODEL OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA
Elizabeth Bering and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi76, https://doi.org/10.1093/neuonc/noy148.311
Published: 05 November 2018
Journal Article
DRES-07. DEFINING THE MECHANISMS OF ACQUIRED RESISTANCE TO TYROSINE KINASE INHIBITORS IN EGFR-DRIVEN GLIOBLASTOMAS USING INTEGRATED KINOME AND TRANSCRIPTOME PROFILING
Abigail Shelton and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi77, https://doi.org/10.1093/neuonc/noy148.314
Published: 05 November 2018
Journal Article
DRES-10. DRD5 IS A MODULATOR OF GLIOMA SUSCEPTIBILITY TO DRD2 ANTAGONISM BY ONC201
Varun Vijay Prabhu and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi77–vi78, https://doi.org/10.1093/neuonc/noy148.317
Published: 05 November 2018
Journal Article
DRES-11. A SYSTEMS APPROACH FOR DETERMINING THE MECHANISM OF RESISTANCE TO TUMOR TREATING FIELDS IN GLIOBLASTOMA
Dongjiang Chen and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi78, https://doi.org/10.1093/neuonc/noy148.318
Published: 05 November 2018
Journal Article
DRES-12. FUNCTIONAL GENETIC APPROACHES TO OVERCOME TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA
Paula Nogales-Gomez and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi78, https://doi.org/10.1093/neuonc/noy148.319
Published: 05 November 2018
Journal Article
DRES-18. SUMO1 AND VALOSIN-CONTAINING PROTEIN REGULATE RETINOID RECEPTOR PROTEIN TURNOVER– A PROCESS DISRUPTED IN GLIOBLASTOMA
Virginia Rodriguez and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi79, https://doi.org/10.1093/neuonc/noy148.325
Published: 05 November 2018
Advertisement
Advertisement